Zileuton
Back to searchMolecule Structure
Scientific Name
Zileuton
Description of the Drug
Zileuton is a leukotriene synthesis inhibitor used in the prophylaxis and treatment of chronic asthma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00744
http://www.drugbank.ca/drugs/DB00744
Brand Name(s)
Zyflo, Zyflo cr
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Dash Pharmaceuticals Llc, Chiesi Usa Inc, Strides Pharma Global Pte Ltd, Lupin Ltd, Rising Pharma Holdings Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Arachidonate 5-lipoxygenase | SINGLE PROTEIN | INHIBITOR | CHEMBL215 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL18251470 | SCHEMBL4209 |
| PharmGKB | PA451955 | |
| Human Metabolome Database | HMDB0014882 | |
| DrugBank | DB00744 | |
| PubChem: Thomson Pharma | 14749468 | |
| PubChem | 60490 | |
| Mcule | MCULE-7670046922 | |
| LINCS | LSM-5084 | |
| Nikkaji | J369.927G | |
| BindingDB | 50000541 | |
| EPA CompTox Dashboard | DTXSID9023752 | |
| DrugCentral | 2862 | |
| Brenda | 3136 | 155090 |
| ChemicalBook | CB1344903 | |
| Guide to Pharmacology | 5297 | |
| rxnorm | ZYFLO | ZILEUTON |
| PubChem: Drugs of the Future | 12014274 | |
| ChEBI | 10112 |
